Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid November 14, 2025 GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. Related posts: More than 1 billion people live in acute poverty. Half are children and many in conflict zones NewJeans’ parents accuse ADOR of “exploiting” Hanni’s residency status and “recklessly disseminating” personal information to media Marco Rubio Kills State Department Anti-Propaganda Shop, Promises ‘Twitter Files’ Sequel Why Not Just Arrest the Protestors? CBP and ICE Officials Muse Post navigation Previous Previous post: The Data Center Resistance Has ArrivedNext Next post: Trump to order investigation into Epstein’s alleged ties with Clinton and banks Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Notify me of follow-up comments by email. Notify me of new posts by email. Related News Africa: U.S. Launches ‘IP for Growth’ Programme to Boost Africa’s Creative Economy August 21, 2026 0 Africa: All of Africa Today – August 21, 2026 August 21, 2026 0
